Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1984 1
1985 1
1988 1
2015 1
2019 2
2020 5
2021 6
2022 11
2023 15
2024 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation.
Chiricozzi A, Ortoncelli M, Schena D, Gori N, Ferrucci SM, Babino G, Napolitano M, Fargnoli MC, Stingeni L, Rossi M, Romanelli M, Balestri R, Pellegrino M, Parodi A, Bertoldi AM, Palazzo G, Antonelli F, Pitino A, Tripepi G, Fabbrocini G, Balato A, Marzano AV, Girolomoni G, Ribero S, Peris K. Chiricozzi A, et al. Among authors: gori n. Am J Clin Dermatol. 2023 Nov;24(6):953-961. doi: 10.1007/s40257-023-00798-0. Epub 2023 Jun 15. Am J Clin Dermatol. 2023. PMID: 37322324 Free PMC article.
Therapeutic Potential of IL-1 Antagonism in Hidradenitis Suppurativa.
Calabrese L, Malvaso D, Coscarella G, Antonelli F, D'Amore A, Gori N, Rubegni P, Peris K, Chiricozzi A. Calabrese L, et al. Among authors: gori n. Biomolecules. 2024 Feb 1;14(2):175. doi: 10.3390/biom14020175. Biomolecules. 2024. PMID: 38397412 Free PMC article. Review.
Gianotti-Crosti Syndrome after SARS-CoV-2 infection.
Gori N, Quattrini L, Chiricozzi A, Sfregola S, Federico F, Peris K. Gori N, et al. Ital J Dermatol Venerol. 2022 Oct;157(5):460-462. doi: 10.23736/S2784-8671.22.07250-4. Ital J Dermatol Venerol. 2022. PMID: 36213977 No abstract available.
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study.
Chiricozzi A, Ferrucci SM, Di Nardo L, Gori N, Balato A, Ortoncelli M, Maurelli M, Galluzzo M, Munera Campos M, Seremet T, Caldarola G, De Simone C, Ippoliti E, Torres T, Gkalpakiotis S, Conrad C, Carrascosa JM, Bianchi L, Argenziano G, Ribero S, Girolomoni G, Marzano AV, Peris K; MEDaCoTRA Study Group. Chiricozzi A, et al. Among authors: gori n. Expert Opin Biol Ther. 2023 Jul-Dec;23(12):1307-1315. doi: 10.1080/14712598.2023.2292627. Epub 2023 Dec 28. Expert Opin Biol Ther. 2023. PMID: 38108300
Biological agents targeting interleukin-13 for atopic dermatitis.
Chiricozzi A, Gori N, Maurelli M, Gisondi P, Caldarola G, De Simone C, Peris K, Girolomoni G. Chiricozzi A, et al. Among authors: gori n. Expert Opin Biol Ther. 2022 May;22(5):651-659. doi: 10.1080/14712598.2022.2035356. Epub 2022 Feb 6. Expert Opin Biol Ther. 2022. PMID: 35081849 Review.
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study.
Avallone G, Cavallo F, Tancredi A, Maronese CA, Bertello M, Fraghì A, Conforti C, Calabrese G, Di Nicola MR, Oddenino GA, Gargiulo L, Gori N, Loi C, Romita P, Piras V, Bonzano L, Tolino E, Paolino G, Napolitano M, Patruno C, Nettis E, Ferreli C, Roccuzzo G, Marozio L, Silvio M, Russo F, Bettolini L, Gallo R, Mercuri SR, Mastorino L, Rossi M, Zalaudek I, Argenziano G, Trave I, Costanzo A, Chiricozzi A, Gurioli C, Foti C, Potenza C, Ferrucci SM, Balato A, Parodi A, Marzano AV, Ortoncelli M, Ribero S, Quaglino P. Avallone G, et al. Among authors: gori n. J Eur Acad Dermatol Venereol. 2024 Sep;38(9):1799-1808. doi: 10.1111/jdv.19794. Epub 2024 Jan 29. J Eur Acad Dermatol Venereol. 2024. PMID: 38284131
Gender differences in adult atopic dermatitis and clinical implication: Results from a nationwide multicentre study.
Marani A, Bianchelli T, Gesuita R, Faragalli A, Foti C, Malara G, Micali G, Amerio P, Rongioletti F, Corazza M, Patrizi A, Peris K, Pimpinelli N, Parodi A, Fargnoli MC, Cannavo SP, Pigatto P, Pellacani G, Ferrucci SM, Argenziano G, Cusano F, Stingeni L, Potenza MC, Romanelli M, Bianchi L, Offidani A, Campanati A; Collaborators. Marani A, et al. J Eur Acad Dermatol Venereol. 2024 Feb;38(2):375-383. doi: 10.1111/jdv.19580. Epub 2023 Dec 13. J Eur Acad Dermatol Venereol. 2024. PMID: 37857489
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series.
Gori N, Ippoliti E, Ferrucci SM, Balato A, Ortoncelli M, Maurelli M, Galluzzo M, Munera Campos M, Seremet T, Di Nardo L, Antonelli F, Coscarella G, Conrad C, Carrascosa JM, Bianchi L, Argenziano G, Ribero S, Girolomoni G, Marzano AV, Chiricozzi A, Peris K; MEDaCoTRA Study Group. Gori N, et al. J Eur Acad Dermatol Venereol. 2024 Oct;38(10):e852-e854. doi: 10.1111/jdv.19929. Epub 2024 Feb 29. J Eur Acad Dermatol Venereol. 2024. PMID: 38421043 No abstract available.
51 results